The global intraoperative radiation therapy market is expected to experience significant growth in the coming years due to the increasing prevalence of cancer and the growing demand for advanced treatments. Additionally, the growing awareness among patients and healthcare professionals about the potential benefits of IORT is expected to further drive the market growth. Furthermore, the increasing acceptance of IORT by healthcare providers and the introduction of technologically advanced equipment are some of the other factors that are anticipated to fuel the growth of the market.
Request For Free Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
Key Market Players
The key growth strategies adopted by the top players in the market are product launches and approvals, agreements, partnerships, mergers and acquisitions, and expansions. Prominent players in the intraoperative radiation therapy market include ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems Inc. (US), Xstrahl Medical (UK), DOSIsoft SA (France), Huiheng Medical (China), Sun Nuclear Corporation (US), and Theragenics Corporation (US).
ZEISS is among the pioneer companies that combined surgery with radiotherapy to develop and introduce intraoperative radiation therapy to the cancer treatment field. The flagship product of the company, INTRABEAM, is one of the most widely used IORT products across the globe. INTRABEAM is a revolutionary, intraoperative form of radiation therapy for early-stage breast cancers. It allows radiation treatment and breast-conserving surgery to be performed simultaneously.
The market is segmented on the basis of product, application, and geography. Based on product, the market is bifurcated into dedicated IORT systems and afterloaders. By application, the market is divided into breast cancer, gynecological cancer, and other cancers. Regionally, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083
This report has segmented the global Intraoperative radiation therapy market into following segments & sub-segments:
By Product & Service
Products
Systems/Accelerators
Applicators & Afterloaders
Treatment Planning Systems
Accessories
Services
By Technology
Electron IORT
Intraoperative Brachytherapy
By Application
Breast Cancer
Brain Tumor
Gastrointestinal Cancer
Head & Neck Cancer
Colorectal Cancer
Endometrial & Cervical Cancer
Lung Cancer
Other Cancers (penile cancer and prostate cancer)
By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Recent Developments
Elekta AB launched Geneva, a universal gynecological applicator for brachytherapy.
Varian acquired Cancer Treatment Services International (CTSI), a US-based oncology solutions division that provides cancer care professional services to healthcare providers worldwide. The acquisition expanded Varian’s access to technology-driven cancer care .
Varian launched the Bravos afterloader system for high-dose-rate (HDR) brachytherapy treatments
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=245000083
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
